Delisting riskPopularity #4,761
Xtant Medical (XTNT)
Supplies orthobiologics, spine implants, and U.S. surgical-hemostasis products.
$0.3647
vs last close+0.03 (+8.22%)
Something off on this page? Send us feedback.
Next report
Nov 10, 26
in 49 days
EPS estimate
−$0.03
Revenue estimate
$25.5M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.02$0.00$0.02$0.01$0.00−$0.02−$0.07Pending
Estimate−$0.01−$0.01−$0.01−$0.01$0.00−$0.02−$0.02−$0.03
Surprise−100.0%+104.0%+300.0%+290.5%—−33.3%−250.0%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$31.5M$32.9M$35.4M$33.3M$32.4M$20.9M$23.0MPending
Estimate$31.8M$31.2M$31.2M$30.8M$30.8M$20.2M$24.9M$25.5M
Surprise−0.9%+5.4%+13.5%+8.1%+5.2%+3.6%−7.4%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | $0.01 | — | — |
| Sep 2028 | −$0.01 | — | — |
| Jun 2028 | −$0.01 | — | — |
| Mar 2028 | −$0.01 | — | — |
| Dec 2027 | $0.01 | — | — |
| Sep 2027 | −$0.01 | — | — |
| Jun 2027 | −$0.02 | — | — |
| Mar 2027 | −$0.02 | — | — |
| Dec 2026 | −$0.01 | — | — |
| Nov 2026 | −$0.03 | — | — |
| Aug 2026 | −$0.02 | −$0.07 | −250.0% |
| May 2026 | −$0.02 | −$0.02 | −33.3% |
| Mar 2026 | $0.00 | $0.00 | — |
| Nov 2025 | −$0.01 | $0.01 | +290.5% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Apr 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Oct 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Apr 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Apr 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| Mar 2018 | |||
| May 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | $0.01 | — | — | $33.7M | — | — | — |
| Sep 2028 | −$0.01 | — | — | $28.4M | — | — | — |
| Jun 2028 | −$0.01 | — | — | $28.1M | — | — | — |
| Mar 2028 | −$0.01 | — | — | $27.4M | — | — | — |
| Dec 2027 | $0.01 | — | — | $31.5M | — | — | — |
| Sep 2027 | −$0.01 | — | — | $26.6M | — | — | — |
| Jun 2027 | −$0.02 | — | — | $26.4M | — | — | — |
| Mar 2027 | −$0.02 | — | — | $25.7M | — | — | — |
| Dec 2026 | −$0.01 | — | — | $30.1M | — | — | — |
| Nov 10, 2026 | −$0.03 | — | — | $25.5M | — | — | — |
| Aug 11, 2026 | −$0.02 | −$0.07 | −250.0% | $24.9M | $23.0M | −7.4% | −28.3% |
| May 13, 2026 | −$0.02 | −$0.02 | −33.3% | $20.2M | $20.9M | +3.6% | −4.8% |
| Mar 31, 2026 | $0.00 | $0.00 | — | $30.8M | $32.4M | +5.2% | +2.8% |
| Nov 10, 2025 | −$0.01 | $0.01 | +290.5% | $30.8M | $33.3M | +8.1% | +1.1% |
| Aug 12, 2025 | |||||||
| May 12, 2025 | |||||||
| Mar 6, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Aug 8, 2024 | |||||||
| May 15, 2024 | |||||||
| Apr 1, 2024 | |||||||
| Nov 9, 2023 | |||||||
| Aug 1, 2023 | |||||||
| May 4, 2023 | |||||||
| Mar 7, 2023 | |||||||
| Nov 3, 2022 | |||||||
| Aug 4, 2022 | |||||||
| May 5, 2022 | |||||||
| Mar 8, 2022 | |||||||
| Nov 12, 2021 | |||||||
| Aug 5, 2021 | |||||||
| May 11, 2021 | |||||||
| Feb 24, 2021 | |||||||
| Oct 29, 2020 | |||||||
| Aug 3, 2020 | |||||||
| May 7, 2020 | |||||||
| Mar 5, 2020 | |||||||
| Nov 7, 2019 | |||||||
| Aug 8, 2019 | |||||||
| May 15, 2019 | |||||||
| Apr 1, 2019 | |||||||
| Nov 14, 2018 | |||||||
| Aug 7, 2018 | |||||||
| May 9, 2018 | |||||||
| Apr 3, 2018 | |||||||
| Nov 21, 2017 | |||||||
| Aug 9, 2017 | |||||||
| Mar 30, 2018 | |||||||
| May 9, 2017 | |||||||
| Nov 7, 2016 | |||||||
| Aug 1, 2016 | |||||||
| May 4, 2016 | |||||||
| Mar 15, 2016 | |||||||
| Nov 11, 2015 | |||||||
| Aug 12, 2015 |